Evaluation of the Hematological and Serum Biochemistry Parameters in the Pre-Symptomatic and Symptomatic Stages of ALS Disease to Support Early Diagnosis and Prognosis
- PMID: 36428998
- PMCID: PMC9688239
- DOI: 10.3390/cells11223569
Evaluation of the Hematological and Serum Biochemistry Parameters in the Pre-Symptomatic and Symptomatic Stages of ALS Disease to Support Early Diagnosis and Prognosis
Abstract
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease. Since there are no pathognomonic tests for ALS prognoses; clinical diagnoses of the disease take time and are usually difficult. Prognostic biomarkers are urgently needed for rapid and effective ALS prognoses. Male albino rats were divided into ten groups based on age: 0 (40-45 days old), A (70-75 days old), B (90-95 days old), C (110-115 days old), and D (130-135 days old). Each group was divided into two subgroups according to its mutation status: wild type (SOD1WT) or mutated (SOD1G93A). Serum biochemistry and hematological parameters were measured in 90 rats to evaluate possible biomarkers for faster ALS diagnoses and prognoses. Weight loss, cholesterol, creatinine, glucose, total bilirubin (TBIL), blood urine nitrogen (BUN), c-peptide, glucagon, PYY, white blood cell (WBC), lymphocyte (LYM), monocyte (MID), granulocyte (GRAN), red cell distribution width with standard deviation (RDW-SD), red cell distribution width with the coefficient of variation (RDW-CV), platelet (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and procalcitonin (PCT) levels were changed in the SOD1G93A rats compared to the SOD1WT rats independently from aging. For the first time in the literature, we showed promising hematological and serum biochemistry parameters in the pre-symptomatic and symptomatic stages of ALS by eliminating the effects of aging. Our results can be used for early diagnoses and prognoses of ALS, improving the quality of life and survival time of ALS patients.
Keywords: ALS; early diagnosis; hematological parameters; pre-symptomatic; serum biochemistry; symptomatic.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model.Neuroscience. 2009 Dec 15;164(3):975-85. doi: 10.1016/j.neuroscience.2009.08.031. Epub 2009 Aug 20. Neuroscience. 2009. PMID: 19699279 Free PMC article.
-
MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis.PLoS One. 2014 Feb 20;9(2):e89065. doi: 10.1371/journal.pone.0089065. eCollection 2014. PLoS One. 2014. PMID: 24586506 Free PMC article.
-
Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.Skelet Muscle. 2016 Jun 23;6:24. doi: 10.1186/s13395-016-0094-6. eCollection 2016. Skelet Muscle. 2016. PMID: 27340545 Free PMC article.
-
[Amyotrophic lateral sclerosis with the SOD1 mutations].Rinsho Shinkeigaku. 2008 Nov;48(11):966-9. doi: 10.5692/clinicalneurol.48.966. Rinsho Shinkeigaku. 2008. PMID: 19198133 Review. Japanese.
-
SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.Adv Biol Regul. 2016 Jan;60:95-104. doi: 10.1016/j.jbior.2015.10.006. Epub 2015 Oct 31. Adv Biol Regul. 2016. PMID: 26563614 Review.
Cited by
-
Neuroprotective Roles of the Biliverdin Reductase-A/Bilirubin Axis in the Brain.Biomolecules. 2024 Jan 28;14(2):155. doi: 10.3390/biom14020155. Biomolecules. 2024. PMID: 38397392 Free PMC article. Review.
-
Gemcitabine-loaded chitosan nanoparticles enhanced apoptotic and ferroptotic response of gemcitabine treatment alone in the pancreatic cancer cells in vitro.Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):9051-9066. doi: 10.1007/s00210-024-03193-6. Epub 2024 Jun 17. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38884675 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous